Stay updated on Avelumab in Chemo-resistant GTN Clinical Trial
Sign up to get notified when there's something new on the Avelumab in Chemo-resistant GTN Clinical Trial page.

Latest updates to the Avelumab in Chemo-resistant GTN Clinical Trial page
- Check6 days agoChange DetectedThe page now presents the full record for the completed Phase II TROPHIMMUN trial of avelumab in chemotherapy-resistant gestational trophoblastic neoplasias, including its design, eligibility criteria, study outcomes, locations, and publications.SummaryDifference48%

- Check13 days agoChange DetectedThe ClinicalTrials.gov footer now identifies the site revision as v3.8.0 instead of v3.7.2. The page continues to show a 403 Forbidden error rather than the study record.SummaryDifference0.2%

- Check27 days agoChange DetectedA general NIH notice about a terminology transition appears above the page, and the site revision changes from v3.7.1 to v3.7.2. The clinical trial page still displays a 403 error.SummaryDifference1%

- Check34 days agoChange DetectedThe footer revision identifier was updated from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check55 days agoChange DetectedLocations and contact information, as well as study record dates and results sections, have been removed. The page now presents a leaner view of the study details with fewer contextual details about where and when the study occurs and its history.SummaryDifference18%

- Check62 days agoChange DetectedThe page's revision tag was updated to v3.7.0, signaling a version update of the study entry. This change reflects a metadata update rather than a modification to the study details.SummaryDifference0.1%

Stay in the know with updates to Avelumab in Chemo-resistant GTN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab in Chemo-resistant GTN Clinical Trial page.